Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Anaplasma phagocytophilum induces actin phosphorylation to selectively regulate gene transcription in Ixodes scapularis ticks.

Sultana H, Neelakanta G, Kantor FS, Malawista SE, Fish D, Montgomery RR, Fikrig E.

J Exp Med. 2010 Aug 2;207(8):1727-43. doi: 10.1084/jem.20100276. Epub 2010 Jul 26. Erratum in: J Exp Med. 2011 Aug 1;208(8):1737.

2.

Role of outer surface protein D in the Borrelia burgdorferi life cycle.

Li X, Neelakanta G, Liu X, Beck DS, Kantor FS, Fish D, Anderson JF, Fikrig E.

Infect Immun. 2007 Sep;75(9):4237-44. Epub 2007 Jul 9.

3.

Outer surface protein B is critical for Borrelia burgdorferi adherence and survival within Ixodes ticks.

Neelakanta G, Li X, Pal U, Liu X, Beck DS, DePonte K, Fish D, Kantor FS, Fikrig E.

PLoS Pathog. 2007 Mar;3(3):e33.

4.

Disruption of the salivary protein 14 in Ixodes scapularis nymphs and impact on pathogen acquisition.

Pedra JH, Narasimhan S, Deponte K, Marcantonio N, Kantor FS, Fikrig E.

Am J Trop Med Hyg. 2006 Oct;75(4):677-82.

PMID:
17038693
5.

An Ixodes scapularis protein required for survival of Anaplasma phagocytophilum in tick salivary glands.

Sukumaran B, Narasimhan S, Anderson JF, DePonte K, Marcantonio N, Krishnan MN, Fish D, Telford SR, Kantor FS, Fikrig E.

J Exp Med. 2006 Jun 12;203(6):1507-17. Epub 2006 May 22.

6.

Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity.

Li X, Liu X, Beck DS, Kantor FS, Fikrig E.

Infect Immun. 2006 Jun;74(6):3305-13.

7.

The Lyme disease agent exploits a tick protein to infect the mammalian host.

Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang XF, Fish D, Anguita J, Norgard MV, Kantor FS, Anderson JF, Koski RA, Fikrig E.

Nature. 2005 Jul 28;436(7050):573-7.

8.

TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi.

Pal U, Li X, Wang T, Montgomery RR, Ramamoorthi N, Desilva AM, Bao F, Yang X, Pypaert M, Pradhan D, Kantor FS, Telford S, Anderson JF, Fikrig E.

Cell. 2004 Nov 12;119(4):457-68.

9.

Disruption of Ixodes scapularis anticoagulation by using RNA interference.

Narasimhan S, Montgomery RR, DePonte K, Tschudi C, Marcantonio N, Anderson JF, Sauer JR, Cappello M, Kantor FS, Fikrig E.

Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1141-6. Epub 2004 Jan 26.

10.

Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation.

Anguita J, Ramamoorthi N, Hovius JW, Das S, Thomas V, Persinski R, Conze D, Askenase PW, Rincón M, Kantor FS, Fikrig E.

Immunity. 2002 Jun;16(6):849-59.

11.

Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands.

Das S, Banerjee G, DePonte K, Marcantonio N, Kantor FS, Fikrig E.

J Infect Dis. 2001 Oct 15;184(8):1056-64. Epub 2001 Sep 28.

PMID:
11574922
12.

SALP16, a gene induced in Ixodes scapularis salivary glands during tick feeding.

Das S, Marcantonio N, Deponte K, Telford SR 3rd, Anderson JF, Kantor FS, Fikrig E.

Am J Trop Med Hyg. 2000 Jan;62(1):99-105.

PMID:
10761732
13.

Prevention of Borrelia burgdorferi transmission in guinea pigs by tick immunity.

Nazario S, Das S, de Silva AM, Deponte K, Marcantonio N, Anderson JF, Fish D, Fikrig E, Kantor FS.

Am J Trop Med Hyg. 1998 Jun;58(6):780-5.

PMID:
9660463
14.

Granulocytic ehrlichiosis in tick-immune guinea pigs.

Das S, Deponte K, Marcantonio NL, Ijdo JW, Hodzic E, Katavolos P, Barthold SW, Telford SR 3rd, Kantor FS, Fikrig E.

Infect Immun. 1998 Apr;66(4):1803-5.

15.

Immune evasion by tickborne and host-adapted Borrelia burgdorferi.

de Silva AM, Fikrig E, Hodzic E, Kantor FS, Telford SR 3rd, Barthold SW.

J Infect Dis. 1998 Feb;177(2):395-400.

PMID:
9466527
16.

Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice.

Bockenstedt LK, Fikrig E, Barthold SW, Flavell RA, Kantor FS.

J Immunol. 1996 Dec 15;157(12):5496-502.

PMID:
8955199
17.

Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans.

Anderson JF, Flavell RA, Magnarelli LA, Barthold SW, Kantor FS, Wallich R, Persing DH, Mathiesen D, Fikrig E.

J Clin Microbiol. 1996 Mar;34(3):524-9.

18.

Efficacy of human Lyme disease vaccine formulations in a mouse model.

Telford SR 3rd, Kantor FS, Lobet Y, Barthold SW, Spielman A, Flavell RA, Fikrig E.

J Infect Dis. 1995 May;171(5):1368-70.

PMID:
7751719
19.

Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.

Fikrig E, Telford SR 3rd, Wallich R, Chen M, Lobet Y, Matuschka FR, Kimsey RB, Kantor FS, Barthold SW, Spielman A, Flavell RA.

J Exp Med. 1995 Jan 1;181(1):215-21.

20.

Disarming Lyme disease.

Kantor FS.

Sci Am. 1994 Sep;271(3):34-9. Review.

PMID:
8091189
21.

Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease.

Lam TT, Nguyen TP, Montgomery RR, Kantor FS, Fikrig E, Flavell RA.

Infect Immun. 1994 Jan;62(1):290-8.

22.

Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice.

Bockenstedt LK, Fikrig E, Barthold SW, Kantor FS, Flavell RA.

J Immunol. 1993 Jul 15;151(2):900-6.

PMID:
8335917
23.

Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement.

Bockenstedt LK, Barthold S, Deponte K, Marcantonio N, Kantor FS.

Infect Immun. 1993 May;61(5):2104-7.

24.

Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.

Fikrig E, Tao H, Kantor FS, Barthold SW, Flavell RA.

Proc Natl Acad Sci U S A. 1993 May 1;90(9):4092-6.

25.

Protective immunity in lyme borreliosis.

Fikrig E, Kantor FS, Barthold SW, Flavell RA.

Parasitol Today. 1993 Apr;9(4):129-31.

PMID:
15463734
26.

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.

Fikrig E, Telford SR 3rd, Barthold SW, Kantor FS, Spielman A, Flavell RA.

Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5418-21.

27.

Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection.

Fikrig E, Barthold SW, Persing DH, Sun X, Kantor FS, Flavell RA.

J Immunol. 1992 Apr 1;148(7):2256-60.

PMID:
1545130
28.

Long-term protection of mice from Lyme disease by vaccination with OspA.

Fikrig E, Barthold SW, Kantor FS, Flavell RA.

Infect Immun. 1992 Mar;60(3):773-7.

29.

Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.

Fikrig E, Barthold SW, Marcantonio N, Deponte K, Kantor FS, Flavell RA.

Infect Immun. 1992 Feb;60(2):657-61.

30.

Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA.

Fikrig E, Barthold SW, Kantor FS, Flavell RA.

J Infect Dis. 1991 Dec;164(6):1224-7.

PMID:
1955724
31.

Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.

Sears JE, Fikrig E, Nakagawa TY, Deponte K, Marcantonio N, Kantor FS, Flavell RA.

J Immunol. 1991 Sep 15;147(6):1995-2000.

PMID:
1716290
32.

Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.

Fikrig E, Barthold SW, Kantor FS, Flavell RA.

Science. 1990 Oct 26;250(4980):553-6.

PMID:
2237407
33.
34.

An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides.

Pachner AR, Kantor FS, Mulac-Jericevic B, Atassi MZ.

Immunol Lett. 1989 Feb;20(3):199-204.

PMID:
2469649
35.

Autoimmunities: diseases of 'dysregulation'.

Kantor FS.

Hosp Pract (Off Ed). 1988 Jul 15;23(7):75-84. No abstract available.

PMID:
3134377
36.

Suppressor T-cell lines and hybridomas in murine myasthenia.

Pachner AR, Kantor FS.

Ann N Y Acad Sci. 1987;505:619-27. No abstract available.

PMID:
2961297
37.

Helper T-cell lines specific for the acetylcholine receptor: induction, characterization, and in vitro effects.

Pachner AR, Kantor FS.

Clin Immunol Immunopathol. 1985 May;35(2):245-51.

PMID:
2934193
41.

Local passive transfer of delayed-type hypersensitivity in the mouse.

Scovern H, Kantor FS.

J Immunol. 1982 Jul;129(1):25-9.

PMID:
6177751
42.

Nerve stimulation test in murine experimental autoimmune myasthenia gravis.

Pachner AR, Kantor FS.

Ann Neurol. 1982 Jan;11(1):48-52.

PMID:
6277236
43.

Desensitization in mice: T-cell requirement for nonspecific suppression of delayed-type hypersensitivity.

Swamy PK, Dwyer JM, Kantor FS.

Cell Immunol. 1981 May 15;60(2):308-13. No abstract available.

PMID:
6972266
44.

Sarcoid.

Kantor FS, Dwyer JM, Mangi RJ.

J Invest Dermatol. 1976 Sep;67(3):470-6.

45.

A canine distemper model of virus-induced anergy.

Mangi RJ, Munyer TP, Krakowka S, Jacoby RO, Kantor FS.

J Infect Dis. 1976 May;133(5):556-63.

PMID:
57199
46.

Comparison of the anergy of sarcoidosis with experimentally induced anergy in guinea pigs.

Dwyer JM, Mangi RJ, Gee B, Kantor FS.

Ann N Y Acad Sci. 1976;278:29-35. Review. No abstract available.

PMID:
786123
47.
48.

Depressed lymphocyte function after measles-mumps-rubella vaccination.

Munyer TP, Mangi RJ, Dolan T, Kantor FS.

J Infect Dis. 1975 Jul;132(1):75-8.

PMID:
1151122
50.

Infection, anergy and cell-mediated immunity.

Kantor FS.

N Engl J Med. 1975 Mar 20;292(12):629-34. Review. No abstract available.

PMID:
46586

Supplemental Content

Loading ...
Support Center